Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

STSASTSA
16 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SATSUMA PHARMACEUTICALS INC

CITADEL ADVISORS LLC previously held 0 shares of STSA (SATSUMA PHARMACEUTICALS INC), worth $0 as of 2023-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$14.4M

Total Shares Change

-958,382

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2023-Q1
Decreased
5,397
-45.5%
$3,7700.0%
0
2022-Q4
New
9,912
-
$8,9210.0%
26
2022-Q3
Exited
0
-100.0%
$00.0%
0
2022-Q2
Decreased
150,954
-18.7%
$624,0000.0%
0
2022-Q1
Decreased
185,610
-82.7%
$706,0000.0%
0
2021-Q4
Increased
1.1M
+0.3%
$4.8M0.0%
27
2021-Q3
Decreased
1.1M
-12.6%
$5M0.0%
0
2021-Q2
Decreased
1.2M
-0.9%
$8.6M0.0%
0
2021-Q1
Increased
1.2M
+239.2%
$7.3M0.0%
44
2020-Q4
Decreased
364,785
-5.8%
$1.7M0.0%
0
2020-Q3
Decreased
387,313
-62.3%
$1.5M0.0%
0
2020-Q2
Increased
1M
+0.8%
$29.6M0.0%
29
2020-Q1
Increased
1M
+0.3%
$22M0.0%
28
2019-Q4
Increased
1M
+6.2%
$20M0.0%
30
2019-Q3
New
958,382
-
$14.4M0.0%
39

Other major holders of STSA: RA CAPITAL MANAGEMENT, L.P., TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used